Larvol Delta - Cingulate-Reports-Safety-Results-from-Final-Phase-3-Trials-for-Lead-ADHD-Asset-CTx1301-On-Track-to-File-for-FDA-Approval-Mid2025

dexmethylphenidate tri-modal release (CTx-1301) - Cingulate Therap

https://www.globenewswire.com/news-release/2025/03/04/3036578/0/en/Cingulate-Reports-Safety-Results-from-Final-Phase-3-Trials-for-Lead-ADHD-Asset-CTx-1301-On-Track-to-File-for-FDA-Approval-Mid-2025.html

Mar 4, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next